AstraZeneca Pharma India Limited, leading bio-pharmaceutical company has bagged the corporate  award for CSR Best Practices category at the 20th NHRD National Conference. The award was given in recognition for the company’s CSR initiative – The Young Health Programme (YHP), a community based initiative focused on primary prevention of non-communicable diseases in young people. AstraZeneca was also a finalist in the category of HR Best Practices for its focus on ‘gender diversity’.    
 
Commenting on the company’s win, Smita Saha, vice president – HR, AstraZeneca Pharma India Limited (AZPIL) said that the award reinforces our commitment to target the various risk behaviours that lead to non-communicable diseases in young people, especially those in marginalised communities.
 
The conference theme was titled ‘Spirit of Entrepreneurship’ and aimed to address the curiosity of young companies that wish to build the DNA of large organisations and the large ones who could learn from nimble young firms. The two-day event brought together international and national speakers of eminence, well-known HR leaders, CHRO’S, CXO’S, entrepreneurs, academics, students and NGOs.
 
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas: Respiratory and Autoimmunity, Cardiovascular and Metabolic Diseases, and Oncology. The company is also active in inflammation, infection and neuroscience through numerous collaborations.